 |
 |
|
|
|
|
Title: |
US5508188:
Method of growing cells in a mammal
[ Derwent Title ]
>> View Certificate of Correction for this publication

|
Country: |
US United States of America

|
| |
Inventor: |
Barsky, Sanford H.; Los Angeles, CA
Sternlicht, Mark; Los Angeles, CA

|
Assignee: |
The Regents of the University of California, Oakland, CA
other patents from UNIVERSITY OF CALIFORNIA, THE REGENTS OF (599425) (approx. 4,840)
News, Profiles, Stocks and More about this company

|
Published / Filed: |
1996-04-16
/ 1994-01-21

|
Application Number: |
US1994000184720

|
IPC Code: |
Advanced:
C12N 5/06;
C12N 5/16;
G01N 33/50;
Core:
more...
IPC-7:
C12N 5/00;
C12N 5/02;

|
ECLA Code: |
C12N5/06B30; C12N5/16; G01N33/50D2B;

|
U.S. Class: |
Current:
435/395;
424/093.7;
435/325;
435/378;
Original:
425/240.2;
435/240.1;
435/240.25;

|
Field of Search: |
424/93.2
435/172.3,240.1,240.2,240.25

|
Priority Number: |
| 1994-01-21 |
US1994000184720 |

|
Abstract: |
Human basement membrane matrix is provided, produced by a novel tumorigenic cell line, where the basement membrane can be used for the growth of a variety of cells, in culture and in vivo. Other cell lines are provided, which may serve to evaluate in vivo the response of tumorigenic cells to various agents, including basement membrane. The basement membrane finds use in allowing the growth of cells in culture and in vivo, particularly cells which are otherwise refractory to xenografting.

|
Attorney, Agent or Firm: |
Rowland, Bertram I. ;

|
Primary / Asst. Examiners: |
Stone, Jacqueline M.; Crouch, Deborah

|
Maintenance Status: |
CC Certificate of Correction issued View Certificate of Correction

|
INPADOC Legal Status: |
Show legal status actions
Family Legal Status Report

|
Designated Country: |
EP JP

|
Family: |
Show 3 known family members

|
First Claim:
Show all 3 claims |
What is claimed is:
1. A method for growing human tumorigenic cells in an immunocompromised mammal host, said method comprising:
- introducing said tumorigenic cells into said mammal host mixed with a basement membrane like composition derived from basement membrane produced by HMS-X cells and comprising from 20-30 weight % heparan/chondroitin sulfate proteoglycan, from about 10-20 weight % fibronectin, 2-10 weight % laminin, about 10 weight % nidogen/entactin and from about 2-10 weight % of each of type I and IV collagen; and
- growing said mammal host for sufficient time for said tumorigenic cells to grow.

|
Background / Summary: |
Show background / summary

|
Drawing Descriptions: |
Show drawing descriptions

|
Description: |
Show description

|
Forward References: |
Show 1 U.S. patent(s) that reference this one

|
|